BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2011
View Archived Issues
Eli Lilly provides update on strategy and pipeline
Read More
New full dopamine D3 receptor agonist CJ-1639 displays potent and selective activity in vivo
Read More
New synthetic aminoglycoside NB-54 shows preclinical potential as Rett syndrome therapy
Read More
First potential diagnostic marker for Churg-Strauss syndrome identified
Read More
Mitsubishi Tanabe Pharma discloses new antiplatelet agents
Read More
Lundbeck patents new phosphodiesterase 10A inhibitors
Read More
Scynexis patents new ciclosporin derivatives for hepatitis C
Read More
Pierre Fabre Medicament discloses new sucrose octasulfates of zinc
Read More
New hepatocyte growth factor receptor inhibitors presented
Read More
Boehringer Ingelheim claims new inhibitors of ribosomal protein S6 kinase alpha-3
Read More
Merck Serono's new prostanoid DP2 receptor antagonist shows potential to treat asthma
Read More
Sanofi discontinues Multaq trial in patients with permanent atrial fibrillation
Read More
Pfizer Japan and Astellas Pharma revise copromotion agreement for Caduet
Read More
GSK announces regulatory update for Votrient in advanced soft tissue sarcoma
Read More
Onconova and SymBio enter license agreement for rigosertib in Japan and Korea
Read More
Sanofi and Genzyme report encouraging phase III data on alemtuzumab in MS
Read More
Generex reports preliminary results from two trials of its mealtime insulin Generex Oral-lyn
Read More
Valeant Pharmaceuticals to acquire Sanofi's Dermik dermatology unit
Read More
Coronado Biosciences secures funds to advance CNDO-201 and CNDO-109
Read More
Qiagen increases offer price for acquisition of Cellestis
Read More
HUYA Bioscience and Liaoning (Benxi) Bio-pharmaceutical Industry Base enter strategic partnership
Read More
Qiagen enters binding agreement to acquire majority stake in Ipsogen
Read More
Amarin completes nonclinical studies for AMR-101 NDA
Read More
Alkermes discontinues development of ALKS-33 in binge eating disorder based on phase II data
Read More
FDA approves Boostrix vaccine for persons over 65 years of age
Read More